Since circulating levels of fetuin-A are increased in obesity, metabolic syndrome, and T2D, and correlate to impaired insulin sensitivity and glucose intolerance [73], they represent a promising biomarker and might serve as a therapeutic target [74]. The gene discussed is INS; the disease is Obesity.